PE20151866A1 - Composiciones nutricionales que contienen un componente peptidico con propiedades estimulantes de adiponectina y usos del mismo - Google Patents

Composiciones nutricionales que contienen un componente peptidico con propiedades estimulantes de adiponectina y usos del mismo

Info

Publication number
PE20151866A1
PE20151866A1 PE2015001975A PE2015001975A PE20151866A1 PE 20151866 A1 PE20151866 A1 PE 20151866A1 PE 2015001975 A PE2015001975 A PE 2015001975A PE 2015001975 A PE2015001975 A PE 2015001975A PE 20151866 A1 PE20151866 A1 PE 20151866A1
Authority
PE
Peru
Prior art keywords
adiponectin
same
nutritional compositions
compositions containing
peptide component
Prior art date
Application number
PE2015001975A
Other languages
English (en)
Inventor
Jurgen Eckel
Manuela Elsen
Gabriele Gross
Tol Eric A F Van
Teartse Tim Lambers
Tania Romacho
Marieke H Schoemaker
Dirk Hondmann
Original Assignee
Mjn Us Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc
Publication of PE20151866A1 publication Critical patent/PE20151866A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A23J3/344—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins of casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

SE REFIERE A COMPOSICIONES NUTRICIONALES QUE ESTIMULAN LA PRODUCCION DE ADIPONECTINA, DICHAS COMPOSICIONES COMPRENDEN UNA FUENTE PROTEICA EQUIVALENTE QUE INCLUYE UN COMPONENTE PEPTIDICO CON PEPTIDOS SELECCIONADOS. LA FUENTE PROTEICA EQUIVALENTE COMPRENDE UNA PROTEINA INTACTA, UNA PROTEINA PARCIALMENTE HIDROLIZADA, O COMBINACIONES DE LAS MISMAS. TAMBIEN SE REFIERE A METODOS PARA PROMOVER UN PESO CORPORAL SALUDABLE EN UN SUJETO, MEDIANTE LA PROPORCION DE UNA COMPOSICION NUTRICIONAL DE LA PRESENTE INVENCION A DICHO SUJETO, INCLUSIVE UN SUJETO PEDIATRICO
PE2015001975A 2013-03-15 2014-03-11 Composiciones nutricionales que contienen un componente peptidico con propiedades estimulantes de adiponectina y usos del mismo PE20151866A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/833,039 US9345741B2 (en) 2013-03-15 2013-03-15 Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof

Publications (1)

Publication Number Publication Date
PE20151866A1 true PE20151866A1 (es) 2016-01-13

Family

ID=50439502

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015001975A PE20151866A1 (es) 2013-03-15 2014-03-11 Composiciones nutricionales que contienen un componente peptidico con propiedades estimulantes de adiponectina y usos del mismo

Country Status (17)

Country Link
US (1) US9345741B2 (es)
EP (1) EP2986161A1 (es)
CN (2) CN105007761A (es)
AR (1) AR095334A1 (es)
AU (1) AU2014237102B2 (es)
BR (1) BR112015018265A2 (es)
CA (1) CA2905773A1 (es)
HK (1) HK1216827A1 (es)
MX (1) MX361721B (es)
MY (1) MY169230A (es)
NZ (1) NZ709984A (es)
PE (1) PE20151866A1 (es)
PH (1) PH12015501870A1 (es)
RU (1) RU2015136674A (es)
SG (2) SG10201901656WA (es)
TW (1) TW201501654A (es)
WO (1) WO2014150557A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10251928B2 (en) 2014-11-06 2019-04-09 Mead Johnson Nutrition Company Nutritional supplements containing a peptide component and uses thereof
US20150290261A1 (en) * 2014-04-10 2015-10-15 Mead Johnson Nutrition Company Methods of use for probiotics and prebiotics
EP3397078A1 (en) 2015-12-28 2018-11-07 Abbott Laboratories Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
US20180161292A1 (en) * 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180160714A1 (en) * 2016-12-12 2018-06-14 Mead Johnson Nutrition Company Nutritional compositions containing butyrate and uses thereof
US20180332881A1 (en) * 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Preterm infant formula containing butyrate and uses thereof
IT202100018509A1 (it) * 2021-07-14 2023-01-14 Biofficina Srls Bevanda funzionale con effetti benefici sulla sindrome metabolica

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2064092C2 (de) 1970-12-28 1983-06-01 Bayer Ag, 5090 Leverkusen Inhibitoren für Glykosidhydrolasen aus Actinomyceten
US3937817A (en) 1973-02-28 1976-02-10 Bayer Aktiengesellschaft Pharmaceutical compositions containing a saccharase inhibitor
GB1475624A (en) 1974-07-22 1977-06-01 Toyama Chemical Co Ltd Polypeptide
FR2474829B1 (fr) 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
FR2474828B1 (fr) 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application
US4491589A (en) 1982-05-17 1985-01-01 The Trustees Of Columbia University In The City Of New York Amino acid solutions for parenteral nutrition and methods of formulation and use
DK589785A (da) 1985-12-18 1987-06-19 Samuelsson Ernst Gunnar Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
IT1190349B (it) 1986-06-16 1988-02-16 Prodotti Formenti Srl Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
FR2608050B1 (fr) 1986-12-15 1990-04-13 Bellon Labor Sa Roger Procede de preparation d'un melange peptidique riche en di- et tri-peptides, utilisable notamment en nutrition artificielle et en dietetique, melange ainsi obtenu, et utilisation de ce melange en nutrition artificielle et en dietetique
US5230902A (en) 1988-04-29 1993-07-27 Immunotec Research Corporation Undenatured whey protein concentrate to improve active systemic humoral immune response
CA1338682C (en) * 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement
US5102871A (en) 1989-04-24 1992-04-07 Kyowa Hakko Kogyo Co., Ltd. Nutrient composition
FI904074A0 (fi) 1989-08-28 1990-08-17 Milupa Ag Protein-, peptid- och aminosyrablandningar med optimerad aminosyrasammansaettning samt deras anvaendning foer framstaellning av naering foer prematur- och dibarn samt av tillsatser till modersmjoelk.
US5407957A (en) 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
PH30997A (en) 1990-03-12 1997-12-23 Ciba Geigy Antipathologenically effective compositions comprising lytic peptides and hydrolytic enzymes.
EP1092352A3 (en) 1991-01-24 2003-08-27 Martek Corporation Microbial oil mixtures and uses thereof
US5308832A (en) 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
US5374567A (en) 1993-05-20 1994-12-20 The United States Of America As Represented By The Secretary Of The Navy Operational amplifier using bipolar junction transistors in silicon-on-sapphire
GB9312369D0 (en) 1993-06-16 1993-07-28 Sandoz Nutrition Ltd Organic compounds
US5405637A (en) 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
US5714472A (en) 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
US5723446A (en) 1993-12-23 1998-03-03 Nestec Ltd. Enteral formulation designed for optimized nutrient absorption and wound healing
US5605893A (en) 1994-03-15 1997-02-25 Children's Hospital Of Los Angeles Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients
US6451368B1 (en) 1994-04-11 2002-09-17 New Zealand Dairy Board Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected
US5643880A (en) 1994-05-26 1997-07-01 Abbott Laboratories Product for inhibition of attachment of H. influenzae to human cells
US5821217A (en) 1995-10-27 1998-10-13 Beth Israel Deaconess Medical Center, Inc. Enteral formulation: low in fat and containing protein hydrolysates
KR100194074B1 (ko) 1996-02-21 1999-06-15 박종헌 글루텐 펩타이드를 유효성분으로 포함하는 미네랄 흡수 촉진제
WO1998002165A1 (en) 1996-07-17 1998-01-22 Nutracorp Scientific, Inc. Appetite suppression
NL1005037C2 (nl) 1997-01-17 1998-07-20 Nl Zuivelonderzoek Inst Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten.
CA2340223A1 (en) 1998-08-12 2000-02-24 Morinaga Milk Industry Co., Ltd. Nutritional compositions for preventing or treating hyperlipoproteinemia
US6077558A (en) 1998-12-23 2000-06-20 Bristol-Myers Squibb Company Elemental nutritional products
US6905702B1 (en) 1999-11-08 2005-06-14 Children's Hospital Los Angeles Methods for regulating blood glucose and appetite suppression in type 2 diabetics
GB9927603D0 (en) 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
EP1112693B1 (en) 1999-12-30 2006-03-22 Kerry Group Services Ltd Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption
NL1014380C2 (nl) 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
US6207638B1 (en) 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
IL134830A0 (en) 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
US7666996B2 (en) 2000-03-01 2010-02-23 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof
AU3409001A (en) 2000-06-28 2002-01-08 Fuji Abrasive Works Novel inulin synthase and process for producing inulin by using the same
AU1142001A (en) 2000-10-19 2002-04-29 Dsm N.V. Protein hydrolysates
WO2003005836A2 (en) 2001-07-10 2003-01-23 Trustees Of Boston University Modified-fat nutritional products useful for preventing or treating obesity
ATE372689T1 (de) 2001-07-18 2007-09-15 Dsm Ip Assets Bv Verfahren zur hydrolyse von milcheiweissen
DE10149668A1 (de) 2001-10-09 2003-04-10 Numico Res B V Insulinmimetische Aminosäuresequenzen
JP2003137804A (ja) 2001-10-31 2003-05-14 Morinaga Milk Ind Co Ltd インターロイキン−１８誘導剤
WO2003044044A1 (fr) 2001-11-21 2003-05-30 Morinaga Milk Industry Co., Ltd. Nouveau peptide exerçant un effet inhibiteur d'angiotensine convertase
EP1359157A1 (en) 2002-04-29 2003-11-05 Société des Produits Nestlé S.A. Metallo-proteinase inhibitory agent
AU2003236689A1 (en) 2002-06-04 2003-12-19 Dsm Ip Assets B.V. Protein hydrolysate rich in tripeptides
FR2841473B1 (fr) 2002-06-27 2004-09-17 Ingredia Utilisation d'au moins un peptide de la caseine s2 a activite inhbitrice de l'enzyme de conversion de l'engiotensine i pour la preparation de medicaments, d'aliments et de complements alimentaires
JP4719465B2 (ja) 2002-09-04 2011-07-06 ディーエスエム アイピー アセッツ ビー．ブイ． インスリン感受性増強剤およびペプチド画分を含む栄養補給用および治療用組成物
TWI317636B (en) 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
AU2003242352A1 (en) 2002-12-29 2004-07-29 Center For Advanced Science And Technology Incubation, Ltd. Adiponectin receptor and gene coding for the same
WO2004098309A1 (en) 2003-05-05 2004-11-18 Unilever N.V. Hydrolysed casein product comprising tripeptides ipp and/ or vpp
ES2746173T3 (es) 2003-09-23 2020-03-05 Dsm Ip Assets Bv Uso de endoproteasas específicas para prolina para hidrolizar péptidos y proteínas
AU2005207891B2 (en) 2004-01-28 2010-04-01 Andromeda Biotech Ltd. Hsp therapy in conjunction with a low antigenicity diet
EP1751179A4 (en) 2004-03-01 2009-03-25 Peptera Pharmaceuticals Ltd PEPTIDES DERIVED FROM THE CASEIN AND THEIR THERAPEUTIC USES
US20080221023A1 (en) 2004-05-27 2008-09-11 Campina Nederland Holding Use of Protein Hydrolysates For the Manufacture of a Medicament For Prophylaxis and/or Treatment of a Dpp-IV Mediated Condition
DE102004040452A1 (de) 2004-08-20 2006-02-23 N.V. Nutricia Peptidgemisch
US20080108548A1 (en) 2004-11-12 2008-05-08 N.V. Nutricia Food Composition For Rapidly Attenuating Inflammatory Responses
DK1831361T3 (da) 2004-12-23 2012-05-14 Campina Nederland Holding Bv Proteinhydrolysat beriget med peptider, som inhiberer DPP-IV, og deres anvendelse
ATE491349T1 (de) 2005-01-18 2011-01-15 Dsm Ip Assets Bv Neue nutrazeutika-zusammensetzungen
DE602006011275D1 (de) 2005-02-03 2010-02-04 Dsm Ip Assets Bv Zusammensetzungen mit epigallocatechingallat und proteinhydrolysat
BRPI0606355A2 (pt) 2005-02-09 2009-06-16 Unilever Nv produto alimentìcio, uso de uma composição, uso de um éster de ácido graxo de esterol e bebidas
DE602006020028D1 (de) 2005-04-28 2011-03-24 Unilever Nv Gesundheitsfördernde peptide und sie enthaltende zusammensetzungen
EP1879605A2 (en) 2005-04-28 2008-01-23 DSMIP Assets B.V. Novel nutraceutical compositions
WO2006118459A1 (en) 2005-04-29 2006-11-09 Campina Nederland Holding B.V. Antiviral peptides
US7618669B2 (en) * 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
US20060286208A1 (en) * 2005-06-01 2006-12-21 Nagendra Rangavajla Methods for producing protein partial hydrolysates and infant formulas containing the same
ES2319475B1 (es) 2005-06-08 2010-02-16 Consejo Superior Investig. Cientificas Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
ES2350907T3 (es) 2005-07-01 2011-01-28 N.V. Nutricia Nutrición para bebés con proteínas hidrolizadas.
JP2009517464A (ja) 2005-11-30 2009-04-30 カンピーナ ネーダーランド ホールディング ビー．ブイ． グルカゴン様ペプチド１の活性を増強するタンパク質加水分解物の使用
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
ATE509624T1 (de) 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
EP1992354B1 (en) 2006-02-09 2014-04-09 Calpis Co., Ltd. Rheumatoid arthritis-preventive agent for oral intake
EP2007792A2 (en) 2006-03-22 2008-12-31 DSMIP Assets B.V. Cholesterol lowering protein hydrolysates
EA200802128A1 (ru) 2006-04-12 2009-04-28 ДСМ АйПи АССЕТС Б.В. Новые нутрицевтические композиции
EP2039366A4 (en) 2006-04-21 2010-01-06 Meiji Seika Kaisha COMPOSITION CONTAINING PEPTIDE AS ACTIVE INGREDIENT
NZ572152A (en) * 2006-04-28 2012-07-27 Megmilk Snow Brand Co Ltd Peptidethat is derived from a milk protein and has an antioxidative effect and also acts as a blood adiponectin level increase promotion and/or decrease inhibition agen
KR20080003637A (ko) 2006-07-03 2008-01-08 한상기 다이어트효과가 우수한 기능성 유산균발효조성물
BRPI0721827B8 (pt) 2006-08-04 2021-05-25 Shs Int Ltd uso de uma composição, e, composição
US8642736B2 (en) 2006-08-09 2014-02-04 Dsm Ip Assets B. V. Casein complexes
NL1032840C2 (nl) 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
NL1033521C2 (nl) 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
NZ581395A (en) 2007-05-14 2012-08-31 Biogen Idec Inc Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
CA2688293A1 (en) 2007-05-25 2008-12-04 Childrens's Medical Center Corporation Dietary formulations and methods for treatment of inflammation and other disorders
AU2008303849A1 (en) 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Therapeutic use of peptide YGLF and combination with KVLPVPQ
JP5620106B2 (ja) 2007-10-24 2014-11-05 株式会社糖鎖工学研究所 増強されたエフェクター機能を有するポリペプチド
US8859210B2 (en) 2008-10-17 2014-10-14 Mead Johnson Nutrition Company Method for identifying allergenic proteins and peptides
JP5735734B2 (ja) 2009-04-16 2015-06-17 雪印メグミルク株式会社 脂質代謝改善剤
EP2295535A1 (en) 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
PL2332428T3 (pl) 2009-12-04 2015-02-27 Mjn Us Holdings Llc Formulacja odżywcza zawierająca hydrolizat zawierający peptydy mleka krowiego i/lub pochodzące z niego peptydy do indukowania tolerancji
ES2569241T5 (es) * 2010-01-19 2019-09-11 Abbott Lab Una composición que comprende Lactobacillus rhamnosus HN001 y prebióticos para su uso en el tratamiento de la enfermedad pulmonar alérgica
US20120322726A1 (en) 2010-02-24 2012-12-20 Morinaga Milk Industry Co., Ltd. Therapeutic agent for eating disorders
EP2514435A1 (en) 2011-04-19 2012-10-24 Nestec S.A. Infant formula for use in the prevention of cardiovascular diseases

Also Published As

Publication number Publication date
US9345741B2 (en) 2016-05-24
WO2014150557A1 (en) 2014-09-25
MY169230A (en) 2019-03-19
AR095334A1 (es) 2015-10-07
RU2015136674A (ru) 2017-04-19
HK1216827A1 (zh) 2016-12-09
NZ709984A (en) 2020-05-29
AU2014237102B2 (en) 2017-04-06
CN105007761A (zh) 2015-10-28
PH12015501870B1 (en) 2015-12-07
CN112806580A (zh) 2021-05-18
EP2986161A1 (en) 2016-02-24
SG10201901656WA (en) 2019-03-28
CA2905773A1 (en) 2014-09-25
MX2015011917A (es) 2015-12-01
BR112015018265A2 (pt) 2017-08-22
AU2014237102A1 (en) 2015-08-13
US20140271586A1 (en) 2014-09-18
TW201501654A (zh) 2015-01-16
SG11201505576PA (en) 2015-08-28
PH12015501870A1 (en) 2015-12-07
MX361721B (es) 2018-12-14

Similar Documents

Publication Publication Date Title
PE20151866A1 (es) Composiciones nutricionales que contienen un componente peptidico con propiedades estimulantes de adiponectina y usos del mismo
EA202090919A1 (ru) Липидные наночастицы для доставки модифицированной рнк, кодирующей полипептид vegf-a
CO2017005995A2 (es) Composiciones para el cuidado bucal y métodos de uso
CL2017000201A1 (es) Composiciones y métodos de uso para tratar trastornos metabólicos
CO2017008079A2 (es) Composiciones para el cuidado bucal y métodos de uso
MX2021006017A (es) Polipeptidos de folistatina y sus usos.
CO2018009995A2 (es) Proteínas de unión y métodos de uso de las mismas
EA201790378A1 (ru) Заключенное в липосому аффинное лекарственное средство
BR112016002199A2 (pt) Proteína anti-garp e usos da mesma
PE20171076A1 (es) Composicion que contiene quitina y proteinas digeribles
BR112016020368A2 (pt) proteínas fc multiméricas
EA201591839A1 (ru) Терапевтические пептиды
PE20151978A1 (es) Composiciones nutricionales que contienen un componente peptidico con propiedades antinflamatorias y usos del mismo
GT201800018A (es) Anticuerpo anti-cd154 con características de unión, funcionalidad y seguridad mejoradas y uso en inmunoterapia humana
CL2020000897A1 (es) Composición de proteínas de guisante que tiene calidad nutricional mejorada.
MD20150109A2 (ro) Construcţii proteice mitocondriale şi utilizările acestora
AR106624A1 (es) Composiciones nutricionales que contienen butirato dietario y usos de las mismas
CO2017012675A2 (es) Péptidos lipidados resistentes a proteasas
CL2017000212A1 (es) Anticuerpos anti proteína similar a angiopoyetina 4 y métodos de uso
BR112017013574A2 (pt) conjugados de aminoácido e peptídeo e usos dos mesmos
UY36261A (es) Anticuerpos anti proteína similar a angiopoyetina-4 (angptl4) y métodos de uso
PE20141826A1 (es) Uso de composiciones nutricionales que incluyen lactoferrina en apoyo a la resistencia a enfermedades y condiciones
PE20151999A1 (es) Composiciones nutricionales que contienen un componente peptidico y usos del mismo
PH12017501979A1 (en) Pharmaceutical compound
EA201700074A1 (ru) Стабильные не содержащие консерванты офтальмологические составы опиоидных антагонистов

Legal Events

Date Code Title Description
FA Abandonment or withdrawal